ArticleMolecular cancer therapeutics2022

Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.